Shopping Cart
- Remove All
- Your shopping cart is currently empty
Ianalumab (FUT8-KO) is a humanized, deglycosylated antibody targeting BAFF-R. It inhibits the interaction between BAFF and BAFF-R, antagonizing the apoptosis protection mediated by BAFF. Additionally, Ianalumab (FUT8-KO) exhibits antibody-dependent cellular cytotoxicity (ADCC) that relies on the activation of effector cells mediated by immune receptor tyrosine-based activation motifs (ITAM).
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 mg | Inquiry | Backorder | |
5 mg | Inquiry | Backorder |
Description | Ianalumab (FUT8-KO) is a humanized, deglycosylated antibody targeting BAFF-R. It inhibits the interaction between BAFF and BAFF-R, antagonizing the apoptosis protection mediated by BAFF. Additionally, Ianalumab (FUT8-KO) exhibits antibody-dependent cellular cytotoxicity (ADCC) that relies on the activation of effector cells mediated by immune receptor tyrosine-based activation motifs (ITAM). |
Molecular Weight | 807 |
Formula | C47H54N10O3 |
Storage | store at -20°C | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.